Anti-Angiogenic Chemotherapy: A Phase II Trial of the Oral 5-Drug Regimen (Thalidomide, Celecoxib, Fenofibrate, Etoposide and Cyclophosphamide) in Patients With Relapsed or Progressive Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Celecoxib; Cyclophosphamide; Etoposide; Fenofibrate; Thalidomide
- Indications Cancer
- Focus Therapeutic Use
- 01 Oct 2014 Biomarkers information updated
- 14 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.